Genprex (GNPX) EPS (Basic) Growth (1y) (2017 - 2025)
Genprex (GNPX) EPS (Basic) Growth (1y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn | 7.74% |
| 2 | Regeneron Pharmaceuticals | 86.46 Bn | 78.47 Bn | 3.93 Bn | -4.72% |
| 3 | Argenx Se | 65.62 Bn | 60.44 Bn | 1.37 Bn | 88.81% |
| 4 | Moderna | 58.37 Bn | 53.24 Bn | 52.00 Mn | 7.59% |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 143.95% |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.43 Bn | 992.69 Mn | 322.67% |
| 7 | BioNTech SE | 28.27 Bn | 9.87 Bn | 668.28 Mn | -147.33% |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 96.41% |
| 9 | Royalty Pharma | 27.23 Bn | 26.40 Bn | - | -16.29% |
| 10 | Genprex | 1.88 Mn | -13.28 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 98.78% |
| Dec 31, 2024 | 75.76% |
| Sep 30, 2024 | 76.88% |
| Jun 30, 2024 | 50.99% |
| Mar 31, 2024 | 50.43% |
| Dec 31, 2023 | 20.31% |
| Sep 30, 2023 | -4.52% |
| Jun 30, 2023 | -27.52% |
| Mar 31, 2023 | -68.79% |
| Dec 31, 2022 | 4.81% |
| Sep 30, 2022 | -77.94% |
| Jun 30, 2022 | -43.70% |
| Mar 31, 2022 | 4.87% |
| Dec 31, 2021 | 2.61% |
| Sep 30, 2021 | -1.68% |
| Jun 30, 2021 | 31.96% |
| Mar 31, 2021 | 41.47% |
| Dec 31, 2020 | 2.75% |
| Sep 30, 2020 | 52.65% |
| Jun 30, 2020 | 47.74% |